221 related articles for article (PubMed ID: 9192810)
1. Overexpression of CDC25A and CDC25B in head and neck cancers.
Gasparotto D; Maestro R; Piccinin S; Vukosavljevic T; Barzan L; Sulfaro S; Boiocchi M
Cancer Res; 1997 Jun; 57(12):2366-8. PubMed ID: 9192810
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc.
Wu W; Fan YH; Kemp BL; Walsh G; Mao L
Cancer Res; 1998 Sep; 58(18):4082-5. PubMed ID: 9751615
[TBL] [Abstract][Full Text] [Related]
3. cdc25 cell cycle-activating phosphatases and c-myc expression in human non-Hodgkin's lymphomas.
Hernández S; Hernández L; Beà S; Cazorla M; Fernández PL; Nadal A; Muntané J; Mallofré C; Montserrat E; Cardesa A; Campo E
Cancer Res; 1998 Apr; 58(8):1762-7. PubMed ID: 9563496
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of CDC25A and CDC25B expression in squamous cell carcinomas of the oesophagus.
Nishioka K; Doki Y; Shiozaki H; Yamamoto H; Tamura S; Yasuda T; Fujiwara Y; Yano M; Miyata H; Kishi K; Nakagawa H; Shamma A; Monden M
Br J Cancer; 2001 Aug; 85(3):412-21. PubMed ID: 11487274
[TBL] [Abstract][Full Text] [Related]
5. CDC25 phosphatases as potential human oncogenes.
Galaktionov K; Lee AK; Eckstein J; Draetta G; Meckler J; Loda M; Beach D
Science; 1995 Sep; 269(5230):1575-7. PubMed ID: 7667636
[TBL] [Abstract][Full Text] [Related]
6. Normal cell cycle and checkpoint responses in mice and cells lacking Cdc25B and Cdc25C protein phosphatases.
Ferguson AM; White LS; Donovan PJ; Piwnica-Worms H
Mol Cell Biol; 2005 Apr; 25(7):2853-60. PubMed ID: 15767688
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of cyclin-dependent kinase-activating CDC25B phosphatase in human gastric carcinomas.
Kudo Y; Yasui W; Ue T; Yamamoto S; Yokozaki H; Nikai H; Tahara E
Jpn J Cancer Res; 1997 Oct; 88(10):947-52. PubMed ID: 9414655
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas.
Xu X; Yamamoto H; Sakon M; Yasui M; Ngan CY; Fukunaga H; Morita T; Ogawa M; Nagano H; Nakamori S; Sekimoto M; Matsuura N; Monden M
Clin Cancer Res; 2003 May; 9(5):1764-72. PubMed ID: 12738732
[TBL] [Abstract][Full Text] [Related]
9. Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein.
Naeger LK; Goodwin EC; Hwang ES; DeFilippis RA; Zhang H; DiMaio D
Cell Growth Differ; 1999 Jun; 10(6):413-22. PubMed ID: 10392903
[TBL] [Abstract][Full Text] [Related]
10. Proteasome-dependent degradation of human CDC25B phosphatase.
Cans C; Ducommun B; Baldin V
Mol Biol Rep; 1999 Apr; 26(1-2):53-7. PubMed ID: 10363647
[TBL] [Abstract][Full Text] [Related]
11. Phosphatases and kinases regulating CDC25 activity in the cell cycle: clinical implications of CDC25 overexpression and potential treatment strategies.
Sur S; Agrawal DK
Mol Cell Biochem; 2016 May; 416(1-2):33-46. PubMed ID: 27038604
[TBL] [Abstract][Full Text] [Related]
12. Two CDC25 homologues are differentially expressed during mouse development.
Wickramasinghe D; Becker S; Ernst MK; Resnick JL; Centanni JM; Tessarollo L; Grabel LB; Donovan PJ
Development; 1995 Jul; 121(7):2047-56. PubMed ID: 7635051
[TBL] [Abstract][Full Text] [Related]
13. A dual-specificity phosphatase Cdc25B is an unstable protein and triggers p34(cdc2)/cyclin B activation in hamster BHK21 cells arrested with hydroxyurea.
Nishijima H; Nishitani H; Seki T; Nishimoto T
J Cell Biol; 1997 Sep; 138(5):1105-16. PubMed ID: 9281587
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes.
Wang Z; Trope CG; Flørenes VA; Suo Z; Nesland JM; Holm R
BMC Cancer; 2010 May; 10():233. PubMed ID: 20500813
[TBL] [Abstract][Full Text] [Related]
15. The cdc25B phosphatase is essential for the G2/M phase transition in human cells.
Lammer C; Wagerer S; Saffrich R; Mertens D; Ansorge W; Hoffmann I
J Cell Sci; 1998 Aug; 111 ( Pt 16)():2445-53. PubMed ID: 9683638
[TBL] [Abstract][Full Text] [Related]
16. Specific interaction between 14-3-3 isoforms and the human CDC25B phosphatase.
Mils V; Baldin V; Goubin F; Pinta I; Papin C; Waye M; Eychene A; Ducommun B
Oncogene; 2000 Mar; 19(10):1257-65. PubMed ID: 10713667
[TBL] [Abstract][Full Text] [Related]
17. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition.
Hoffmann I; Draetta G; Karsenti E
EMBO J; 1994 Sep; 13(18):4302-10. PubMed ID: 7523110
[TBL] [Abstract][Full Text] [Related]
18. CDC25B and p53 are independently implicated in radiation sensitivity for human esophageal cancers.
Miyata H; Doki Y; Shiozaki H; Inoue M; Yano M; Fujiwara Y; Yamamoto H; Nishioka K; Kishi K; Monden M
Clin Cancer Res; 2000 Dec; 6(12):4859-65. PubMed ID: 11156245
[TBL] [Abstract][Full Text] [Related]
19. Cdc25B and Cdc25C differ markedly in their properties as initiators of mitosis.
Karlsson C; Katich S; Hagting A; Hoffmann I; Pines J
J Cell Biol; 1999 Aug; 146(3):573-84. PubMed ID: 10444066
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle-related phosphatases CDC25A and B expression correlates with survival in ovarian cancer patients.
Broggini M; Buraggi G; Brenna A; Riva L; Codegoni AM; Torri V; Lissoni AA; Mangioni C; D'Incalci M
Anticancer Res; 2000; 20(6C):4835-40. PubMed ID: 11205229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
